Latest Diabetes News
Additional focus on lifestyle management, self-management education and support emphasized
Findings based on data reweighted to reflect the adult population with diabetes in the US.
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria.
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Finnish study of individuals with type 2 diabetes reveals a 17% and 42% higher incidence of bladder and kidney cancer, respectively, compared with the general population.
New study reveals a type 2 diabetes incidence rate of 17.81 cases per 1000 person-years, a rate much higher than in the general population.
Measurement of plasma copeptin better than water-deprivation test in patients with hypotonic polyuria.
Associated with increased risk of myocardial infarction, all-cause mortality, severe hypoglycemia.
Changes will describe hypoglycemic coma and clarify and identify mental health side effects.
Increased risk seen for women but not men; slightly attenuated after adjustment for mediating factors.
Eversense CGM, which has fully implantable sensor to detect glucose, approved for adults with diabetes.
Metformin plus androgen deprivation therapy is associated with a lower death risk vs ADT alone in men without diabetes, study of US veterans shows.
Better glycemic control than conventional subcutaneous insulin therapy in patients with T2DM.
In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years.
Target HbA1c 7 to 8 for most patients with T2DM; deintensification of tx with HbA1c 6.5
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)